On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...
The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE ... were arthralgia, COVID-19, nasopharyngitis, and fatigue. One participant on DOR/ISL discontinued due to a drug-related serious AE (immune ...
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
On March 4, 2025, filings revealed that CEO Stephane Bancel purchased 160,314 shares of MRNA stock between $31.04 and $31.53, ...
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company"), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot ...
Only seven countries met World Health Organization (WHO) air quality standards last year, data showed on Tuesday, as ...
Exein, the embedded IoT cybersecurity company, and Supermicro, a global leader in application-optimized total IT solutions, have announced a partnership to redefine embedded security. Exein and ...
The app attracted a lot of attention during the pandemic as a potentially way to differentiate COVID-19 from other respiratory infections, but Merck says ... first-in-class drug for chronic ...
Trump’s demand for firms to relocate to the US could be a problem for Ireland as big pharma may be pushed to consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results